B2i Digital Featured Company_Allarity Therapeutics Inc_Nasdaq ALLR_Logo White


Allarity Therapeutics, Inc.

Allarity Therapeutics is a clinical-stage precision medicine company actively advancing stenoparib, an orally available, small molecule inhibitor for patients with advanced recurrent ovarian cancer. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes.

Nasdaq: ALLR
IR Website: allarity.com/investor-overview
Headquarters: Boston, MA

   x-logo   linkedin-logo-white     

Press Releases & Media Coverage

Social Media Updates

Investor Presentation

Stock Chart (Historical)

Stock Detail

Executive Team

SEC Filings


Risks & Disclosures